gss

 Today, Nate Schema, Good Samaritan Society president and CEO leads a conversation on the challenges and the opportunities facing the long-term care industry. Joining Nate are Dana Bachmeier and Luke Wanous. 

Learn more about Sanford Health at: http://www.news.sanfordhealth.org
Connect with us on social:
Facebook
Twitter
Instagram
LinkedIn

US stocks rallied for the third straight day as equities climbed back to record highs. Investors bought into oil, tourism and vaccine stocks. 

Following the US, the Aussie share market is set to open higher. 

What to watch today: 

• ASX listed vaccine developers are likely to rally, such as CSL (ASX:CSL) and Telix Pharmaceuticals (ASX:TLX). This follows the US overnight, where Pfizer shares rose over 2%, BioNTech shares rose about 10%, Moderna rose 9%, and Trillium Therapeutics soared 188% off the back of news of a Pfizer takeover. 
• Expect oil stocks to charge. After the oil price jumped 6%, it partially recovered from its 9% pull back. This is its biggest weekly decline in 9 months. 
• The copper price jumped 1.9%. This supports stocks such as BHP (ASX:BHP) and Oz Minerals (ASX:OZL). 
• Company earnings results today: 
  • Seek (ASX:SEK) reported a net profit of $752 million in the 2021 financial year, rebounding from 2020’s loss of $113 million. As for the current financial year, SEK guided that profit will be lower, between $190 million and $200 million, amid unprecedented COVID-19 conditions. 
  • Boral (ASX:BLD) recovered from a $1.1 billion loss in 2020, swinging profit in FY21 to $639.9 million. This is an 156% improvement, beating market expectations of $260 million. The company will not be paying a final dividend, to preserve capital and remain cautious of COVID-19 conditions. 
  • Johns Lyng Group (ASX:JLG) reported net profit grew 17% in the full year to $18.6 million, missing expectations of $21.2 million profit. 
  • Western Areas (ASX:WSA) reported net loss after tax of $7.7 million, in line with expectations. 
  • AMA (ASX:AMA) reported a net loss of $97 million, after the market expected a profit. AMA declared it is unable to pay a final dividend. 
  • McMillan Shakespeare (ASX:MMS) reported net profit of $61 million. 

Trading Ideas: 

• Best & Less (ASX:BST) was initiated as a Bell Potter BUY rating, with a price target of $3.30, implying 30% share price growth in a year. 
• Openpay Group (ASX:OPY), Genetic Signatures (ASX:GSS) and Arometrex (ASX:AMX) are all giving off bullish charting signals, according to Trading Central. 

As of today, 23% of the world’s population have received their first dose of the COVID-19 vaccine, according to Our World in Data. 

Overnight, big tech names Zoom, Facebook and Peloton all increased over 4%. 

Today, the futures are suggesting a negative day for the Aussie share market, given there are two days until the EOFY and three of Australia’s capital cities are in lockdown. 

What to watch today: 

• With two days until the EOFY, institutional investors are rebalancing their portfolios to sell stocks that have done well over the year, and buy those that have underperformed. With this in mind, stocks that are up 40 to 90% this year include mining stocks Chalice Gold Mines (ASX:CHN), Pilbara Minerals (ASX:PLS) and Codan (ASX:CDA). Banking stocks include Virgin Money (ASX:VUK) and Westpac (ASX:WBC), and building stocks include Reece Group (ASX:REH) and Boral (ASX:BLD). Uniti Group (ASX:UWL) is also one to watch.  
• COVID-19 restrictions and lockdowns are currently in place in Perth, Sydney and Darwin, so watch travel, tourism, hospitality and retail stocks. 
• Prime Minister Scott Morrison has announced that anyone under 40 years old can receive the AstraZeneca vaccine. 
• The iron ore price continued its recovery rising 0.4% to US$215.00. 
• The oil price is down to US$72.00 a barrel. 

Trading Ideas: 

• Bapcor (ASX:BAP) was upgraded by Citi overnight with a new $9.55 price target.
• Genetic Signatures (ASX:GSS) was reiterated as a Bell Potter Speculative BUY with a slimmer $2.20 price target. 
• VGI Partners (ASX:VGI), Kogan (ASX:KGN) and Rudbubble (ASX:RBL) are all giving off bullish charting signals according to Trading Central.